Molecular markers for ischemia, do we have something better than creatinine and glomerular filtration rate?

Archivos Espanoles de Urologia

Volumn 66, Issue 1, 2013, Pages 99-114

  Sprenkle, Preston ^a   Russo, Paul ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Acute kidney injury; Biological markers; Creatinine; Glomerular filtration rate; Ischemia; Renal cancer; Small renal masses

Indexed keywords

ACETYLGLUCOSAMINIDASE; BETA GLUCURONIDASE; BIOLOGICAL MARKER; CREATININE; CYSTATIN C; FATTY ACID BINDING PROTEIN; HAVCR1 PROTEIN, HUMAN; HEAT SHOCK PROTEIN 72; KLOTHO PROTEIN; LEUKOCYTE ELASTASE; LIPOCALIN; MEMBRANE PROTEIN; VIRUS RECEPTOR;

ACUTE KIDNEY FAILURE; ARTICLE; BLOOD; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION TEST; LIVER; META ANALYSIS; METABOLISM; PHYSIOLOGY; STANDARD;

ACETYLGLUCOSAMINIDASE; ACUTE KIDNEY INJURY; BIOLOGICAL MARKERS; CREATININE; CYSTATIN C; FATTY ACID-BINDING PROTEINS; GLOMERULAR FILTRATION RATE; GLUCURONIDASE; HSP72 HEAT-SHOCK PROTEINS; HUMANS; KIDNEY FUNCTION TESTS; LEUKOCYTE ELASTASE; LIPOCALINS; LIVER; MEMBRANE GLYCOPROTEINS; RECEPTORS, VIRUS;

EID: 84873978469     PISSN: 00040614     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (139)

1. Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int, 2004, 66: 486-91.
2. Liano F, Pascual J. Epidemiology of acute renal failure: A prospective, multicenter, community-based study. Madrid acute renal failure study group. Kidney Int, 1996, 50: 811-8.
3. Waikar SS, Curhan GC, Wald R et al. Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol, 2006, 17: 1143-50.
4. Xue JL, Daniels F, Star RA et al. Incidence and mortality of acute renal failure in medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol, 2006, 17: 1135-42.
5. Kelly KJ. Acute renal failure: Much more than a kidney disease. Semin Nephrol, 2006, 26: 105-13.
6. Lameire N, Van Biesen W, Vanholder R. The changing epidemiology of acute renal failure. Nat Clin Pract Nephrol, 2006, 2: 364-77.
7. Kashyap VS, Cambria RP, Davison JK et al. Renal failure after thoracoabdominal aortic surgery. J Vasc Surg, 1997, 26: 949-55; discussion 55-7.
8. Chertow GM, Levy EM, Hammermeister KE et al. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med, 1998, 104: 343-8.
9. Parikh CR, McSweeney P, Schrier RW. Acute renal failure independently predicts mortality after myeloablative allogeneic hematopoietic cell transplant. Kidney Int, 2005, 67: 1999-2005.
10. Bates DW, Su L, Yu DT et al. Mortality and costs of acute renal failure associated with amphotericin b therapy. Clin Infect Dis, 2001, 32: 686-93.
11. Aggarwal A, Ong JP, Younossi ZM et al. Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical icu. Chest, 2001, 119: 1489-97.
12. Lane BR, Poggio ED, Herts BR et al. Renal function assessment in the era of chronic kidney disease: Renewed emphasis on renal function centered patient care. J Urol, 2009, 182: 435-43; discussion 43-4.
13. Pettus JA, Jang TL, Thompson RH et al. Effect of baseline glomerular filtration rate on survival in patients undergoing partial or radical nephrectomy for renal cortical tumors. Mayo Clin Proc, 2008, 83: 1101-6.
14. Lane BR, Fergany AF, Weight CJ et al. Renal functional outcomes after partial nephrectomy with extended ischemic intervals are better than after radical nephrectomy. J Urol, 2010, 184: 1286-90.
15. Huang WC, Levey AS, Serio AM et al. Chronic kidney disease after nephrectomy in patients with renal cortical tumours: A retrospective cohort study. The lancet oncology, 2006, 7: 735-40.
16. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med, 2004, 351: 1296-305.
17. McKiernan J, Simmons R, Katz J et al. Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology, 2002, 59: 816-20.
18. Lau WK, Blute ML, Weaver AL et al. Matched comparison of radical nephrectomy vs nephronsparing surgery in patients with unilateral renal cell carcinoma and a normal contralateral kidney. Mayo Clin Proc, 2000, 75: 1236-42.
19. Huang WC, Elkin EB, Levey AS et al. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors - is there a difference in mortality and cardiovascular outcomes? J Urol, 2009, 181: 55-61; discussion 61-2.
20. Sprenkle PC, Power N, Ghoneim T et al. Comparison of open and minimally invasive partial nephrectomy for renal tumors 4-7 centimeters. Eur Urol, 2011
21. Bellomo R, Ronco C, Kellum JA et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: The second international consensus conference of the acute dialysis quality initiative (adqi) group. Crit Care, 2004, 8: R204-12.
22. Mehta RL, Kellum JA, Shah SV et al. Acute kidney injury network: Report of an initiative to improve outcomes in acute kidney injury. Crit Care, 2007, 11: R31.
23. Chertow GM, Burdick E, Honour M et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol, 2005, 16: 3365-70.
24. Srisawat N, Hoste EE, Kellum JA. Modern classification of acute kidney injury. Blood Purif, 2010, 29: 300-7.
25. Price JF, Mott AR, Dickerson HA et al. Worsening renal function in children hospitalized with decompensated heart failure: Evidence for a pediatric cardiorenal syndrome? Pediatr Crit Care Med, 2008, 9: 279-84.
26. Washburn KK, Zappitelli M, Arikan AA et al. Urinary interleukin-18 is an acute kidney injury biomarker in critically ill children. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, 2008, 23: 566-72.
27. Akcay A, Nguyen Q, Edelstein CL. Mediators of inflammation in acute kidney injury. Mediators Inflamm, 2009, 2009: 137072.
28. Devarajan P. Neutrophil gelatinase-associated lipocalin: A promising biomarker for human acute kidney injury. Biomark Med, 2010, 4: 265-80.
29. Yeo C KR. Neutrophil gelatinase associated lipocalin: An emerging biomarker for acute kidney injury in cardiovascular disease. Proceedings of Singapore Healthcare, 2011, 20: 291-300.
30. Shemesh O, Golbetz H, Kriss JP et al. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int, 1985, 28: 830-8.
31. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: New insights into old concepts. Clin Chem, 1992, 38: 1933-53.
32. Hotchkiss RS, Swanson PE, Freeman BD et al. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med, 1999, 27: 1230-51.
33. Stevens LA, Levey AS. Clinical implications of estimating equations for glomerular filtration rate. Ann Intern Med, 2004, 141: 959-61.
34. Uchino S, Bellomo R, Goldsmith D et al. An assessment of the rifle criteria for acute renal failure in hospitalized patients. Crit Care Med, 2006, 34: 1913-7.
35. Haase M, Bellomo R, Matalanis G et al. A comparison of the rifle and acute kidney injury network classifications for cardiac surgery-associated acute kidney injury: A prospective cohort study. J Thorac Cardiovasc Surg, 2009, 138: 1370-6.
36. Haase-Fielitz A, Bellomo R, Devarajan P et al. Novel and conventional serum biomarkers predicting acute kidney injury in adult cardiac surgery - a prospective cohort study. Crit Care Med, 2009, 37: 553-60.
37. Mishra J, Dent C, Tarabishi R et al. Neutrophil gelatinase-associated lipocalin (ngal) as a biomarker for acute renal injury after cardiac surgery. Lancet, 2005, 365: 1231-8.
38. Cruz DN, de Cal M, Garzotto F et al. Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult icu population. Intensive Care Med, 2010, 36: 444-51.
39. Vaidya VS, Ozer JS, Dieterle F et al. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol, 2010, 28: 478-85.
40. Dieterle F, Sistare F, Goodsaid F et al. Renal biomarker qualification submission: A dialog between the fda-emea and predictive safety testing consortium. Nat Biotechnol, 2010, 28: 455-62.
41. Sharma RK. Biomarkers of acute kidney injury. Clinical Queries: Nephrology, 2012, 0101: 13-17.
42. Nguyen MT, Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol, 2008, 23: 2151-7.
43. Mishra J, Ma Q, Prada A et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol, 2003, 14: 2534-43.
44. Mori K, Lee HT, Rapoport D et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest, 2005, 115: 610-21.
45. Mishra J, Mori K, Ma Q et al. Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol, 2004, 15: 3073-82.
46. Haase M, Bellomo R, Haase-Fielitz A. Novel biomarkers, oxidative stress, and the role of labile iron toxicity in cardiopulmonary bypass-associated acute kidney injury. J Am Coll Cardiol, 2010, 55: 2024-33.
47. Endre ZH, Pickering JW, Walker RJ et al. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int, 2011, 79: 1119-30.
48. Koyner JL, Vaidya VS, Bennett MR et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol, 2010, 5: 2154-65.
49. Parikh CR, Jani A, Mishra J et al. Urine ngal and il-18 are predictive biomarkers for delayed graft function following kidney transplantation. Am J Transplant, 2006, 6: 1639-45.
50. Bennett M, Dent CL, Ma Q et al. Urine ngal predicts severity of acute kidney injury after cardiac surgery: A prospective study. Clin J Am Soc Nephrol, 2008, 3: 665-73.
51. Makris K, Markou N, Evodia E et al. Urinary neutrophil gelatinase-associated lipocalin (ngal) as an early marker of acute kidney injury in critically ill multiple trauma patients. Clin Chem Lab Med, 2009, 47: 79-82.
52. Dent CL, Ma Q, Dastrala S et al. Plasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: A prospective uncontrolled cohort study. Crit Care, 2007, 11: R127.
53. Haase M, Bellomo R, Devarajan P et al. Accuracy of neutrophil gelatinase-associated lipocalin (ngal) in diagnosis and prognosis in acute kidney injury: A systematic review and meta-analysis. American journal of kidney diseases: the official journal of the National Kidney Foundation, 2009, 54: 1012-24.
54. de Geus HR, Bakker J, Lesaffre EM et al. Neutrophil gelatinase-associated lipocalin at icu admission predicts for acute kidney injury in adult patients. American journal of respiratory and critical care medicine, 2011, 183: 907-14.
55. Haase-Fielitz A, Bellomo R, Devarajan P et al. The predictive performance of plasma neutrophil gelatinase-associated lipocalin (ngal) increases with grade of acute kidney injury. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, 2009, 24: 3349-54.
56. Parikh CR, Devarajan P, Zappitelli M et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol, 2011, 22: 1748-57.
57. Haase M, Devarajan P, Haase-Fielitz A et al. The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: A multicenter pooled analysis of prospective studies. J Am Coll Cardiol, 2011, 57: 1752-61.
58. Devarajan P. Review: Neutrophil gelatinase-associated lipocalin: A troponin-like biomarker for human acute kidney injury. Nephrology (Carlton), 2010, 15: 419-28.
59. Wagener G, Gubitosa G, Wang S et al. Urinary neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery. American journal of kidney diseases: the official journal of the National Kidney Foundation, 2008, 52: 425-33.
60. Siew ED, Ware LB, Gebretsadik T et al. Urine neutrophil gelatinase-associated lipocalin moderately predicts acute kidney injury in critically ill adults. J Am Soc Nephrol, 2009, 20: 1823-32.
61. Nickolas TL, Schmidt-Ott KM, Canetta P et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage a multicenter prospective cohort study. J Am Coll Cardiol, 2012, 59: 246-55.
62. Hamada Y, Kanda T, Anzai T et al. N-acetyl-beta-d-glucosaminidase is not a predictor, but an indicator of kidney injury in patients with cardiac surgery. Journal of medicine, 1999, 30: 329-36.
63. McIlroy DR, Wagener G, Lee HT. Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: The effect of baseline renal function on diagnostic performance. Clin J Am Soc Nephrol, 2010, 5: 211-9.
64. van Timmeren MM, van den Heuvel MC, Bailly V et al. Tubular kidney injury molecule-1 (kim-1) in human renal disease. The Journal of pathology, 2007, 212: 209-17.
65. Tuladhar SM, Puntmann VO, Soni M et al. Rapid detection of acute kidney injury by plasma and urinary neutrophil gelatinase-associated lipocalin after cardiopulmonary bypass. J Cardiovasc Pharmacol, 2009, 53: 261-6.
66. Koyner JL, Bennett MR, Worcester EM et al. Urinary cystatin c as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int, 2008, 74: 1059-69.
67. McIlroy DR, Wagener G, Lee HT. Biomarkers of acute kidney injury: An evolving domain. Anesthesiology, 2010, 112: 998-1004.
68. Parikh CR, Jani A, Melnikov VY et al. Urinary interleukin-18 is a marker of human acute tubular necrosis. American journal of kidney diseases: the official journal of the National Kidney Foundation, 2004, 43: 405-14.
69. Westhuyzen J, Endre ZH, Reece G et al. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, 2003, 18: 543-51.
70. Ikenaga H, Suzuki H, Ishii N et al. Enzymuria in non-insulin-dependent diabetic patients: Signs of tubular cell dysfunction. Clinical science, 1993, 84: 469-75.
71. Ascione R, Lloyd CT, Underwood MJ et al. On-pump versus off-pump coronary revascularization: Evaluation of renal function. The Annals of thoracic surgery, 1999, 68: 493-8.
72. Liangos O, Perianayagam MC, Vaidya VS et al. Urinary n-acetyl-beta-(d)- glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol, 2007, 18: 904-12.
73. Chew SL, Lins RL, Daelemans R et al. Urinary enzymes in acute renal failure. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, 1993, 8: 507-11.
74. Hei ZQ, Li XY, Shen N et al. Prognostic values of serum cystatin c and beta2 microglobulin, urinary beta2 microglobulin and n-acetyl-beta-d- glucosaminidase in early acute renal failure after liver transplantation. Chin Med J (Engl), 2008, 121: 1251-6.
75. Oktem F, Ozguner F, Sulak O et al. Lithium-induced renal toxicity in rats: Protection by a novel antioxidant caffeic acid phenethyl ester. Mol Cell Biochem, 2005, 277: 109-15.
76. Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annual review of pharmacology and toxicology, 2008, 48: 463-93.
77. Iqbal MP, Ali AA, Waqar MA et al. Urinary n-acetyl-beta-d-glucosaminidase in rheumatoid arthritis. Experimental & molecular medicine, 1998, 30: 165-9.
78. Fujita H, Narita T, Morii T et al. Increased urinary excretion of n-acetylglucosaminidase in subjects with impaired glucose tolerance. Renal failure, 2002, 24: 69-75.
79. Tominaga M, Fujiyama K, Hoshino T et al. Urinary n-acetyl-beta-d- glucosaminidase in the patients with hyperthyroidism. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1989, 21: 438-40.
80. Bondiou MT, Bourbouze R, Bernard M et al. Inhibition of a and b n-acetyl-beta-d-glucosaminidase urinary isoenzymes by urea. Clinica chimica acta; international journal of clinical chemistry, 1985, 149: 67-73.
81. Vaidya VS, Shankar K, Lock EA et al. Role of tissue repair in survival from s-(1,2-dichlorovinyl)-l-cysteine-induced acute renal tubular necrosis in the mouse. Toxicological sciences: an official journal of the Society of Toxicology, 2003, 74: 215-27.
82. Melnikov VY, Faubel S, Siegmund B et al. Neutrophil-independent mechanisms of caspase-1- and il-18-mediated ischemic acute tubular necrosis in mice. J Clin Invest, 2002, 110: 1083-91.
83. Melnikov VY, Ecder T, Fantuzzi G et al. Impaired il-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest, 2001, 107: 1145-52.
84. Parikh CR, Mishra J, Thiessen-Philbrook H et al. Urinary il-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney Int, 2006, 70: 199-203.
85. Parikh CR, Abraham E, Ancukiewicz M et al. Urine il-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol, 2005, 16: 3046-52.
86. Parikh CR, Devarajan P, Zappitelli M et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol, 2011, 22: 1737-47.
87. Barrera-Chimal J, Perez-Villalva R, Cortes-Gonzalez C et al. Hsp72 is an early and sensitive biomarker to detect acute kidney injury. EMBO Mol Med, 2011, 3: 5-20.
88. Leslie JA, Meldrum KK. The role of interleukin-18 in renal injury. The Journal of surgical research, 2008, 145: 170-5.
89. Crispin JC, Alcocer-Varela J, de Pablo P et al. Immunoregulatory defects in patients with systemic lupus erythematosus in clinical remission. Lupus, 2003, 12: 386-93.
90. Han WK, Bailly V, Abichandani R et al. Kidney injury molecule-1 (kim-1): A novel biomarker for human renal proximal tubule injury. Kidney Int, 2002, 62: 237-44.
91. Ichimura T, Bonventre JV, Bailly V et al. Kidney injury molecule-1 (kim-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem, 1998, 273: 4135-42.
92. Ichimura T, Hung CC, Yang SA et al. Kidney injury molecule-1: A tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol, 2004, 286: F552-63.
93. Vaidya VS, Ramirez V, Ichimura T et al. Urinary kidney injury molecule-1: A sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol, 2006, 290: F517-29.
94. Feigelstock D, Thompson P, Mattoo P et al. Polymorphisms of the hepatitis a virus cellular receptor 1 in african green monkey kidney cells result in antigenic variants that do not react with protective monoclonal antibody 190/4. J Virol, 1998, 72: 6218-22.
95. Feigelstock D, Thompson P, Mattoo P et al. The human homolog of havcr-1 codes for a hepatitis a virus cellular receptor. J Virol, 1998, 72: 6621-8.
96. Kuchroo VK, Umetsu DT, DeKruyff RH et al. The tim gene family: Emerging roles in immunity and disease. Nat Rev Immunol, 2003, 3: 454-62.
97. Han WK, Wagener G, Zhu Y et al. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol, 2009, 4: 873-82.
98. Krawczeski CD, Goldstein SL, Woo JG et al. Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass. J Am Coll Cardiol, 2011, 58: 2301-9.
99. Han WK, Waikar SS, Johnson A et al. Urinary biomarkers in the early diagnosis of acute kidney injury. Kidney Int, 2008, 73: 863-9.
100. Han WK, Alinani A, Wu CL et al. Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma. J Am Soc Nephrol, 2005, 16: 1126-34.
101. Morrissey JJ, London AN, Lambert MC et al. Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma. American journal of nephrology, 2011, 34: 391-8.
102. Zhou Y, Vaidya VS, Brown RP et al. Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicological sciences: an official journal of the Society of Toxicology, 2008, 101: 159-70.
103. Maatman RG, van de Westerlo EM, van Kuppevelt TH et al. Molecular identification of the liver- and the heart-type fatty acid-binding proteins in human and rat kidney. Use of the reverse transcriptase polymerase chain reaction. The Biochemical journal, 1992, 288 (Pt 1): 285-90.
104. Negishi K, Noiri E, Doi K et al. Monitoring of urinary l-type fatty acid-binding protein predicts histological severity of acute kidney injury. The American journal of pathology, 2009, 174: 1154-9.
105. Negishi K, Noiri E, Sugaya T et al. A role of liver fatty acid-binding protein in cisplatin-induced acute renal failure. Kidney Int, 2007, 72: 348-58.
106. Nakamura T, Sugaya T, Kawagoe Y et al. Urinary liver-type fatty acid-binding protein levels for differential diagnosis of idiopathic focal glomerulosclerosis and minor glomerular abnormalities and effect of low-density lipoprotein apheresis. Clinical nephrology, 2006, 65: 1-6.
107. Portilla D, Dent C, Sugaya T et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int, 2008, 73: 465-72.
108. Doi K, Noiri E, Maeda-Mamiya R et al. Urinary l-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury. Crit Care Med, 2010, 38: 2037-42.
109. Oyama Y, Takeda T, Hama H et al. Evidence for megalin-mediated proximal tubular uptake of l-fabp, a carrier of potentially nephrotoxic molecules. Laboratory investigation; a journal of technical methods and pathology, 2005, 85: 522-31.
110. Kamijo-Ikemori A, Sugaya T, Kimura K. Urinary fatty acid binding protein in renal disease. Clinica chimica acta; international journal of clinical chemistry, 2006, 374: 1-7.
111. Kamijo A, Sugaya T, Hikawa A et al. Clinical evaluation of urinary excretion of liver-type fatty acid-binding protein as a marker for the monitoring of chronic kidney disease: A multicenter trial. The Journal of laboratory and clinical medicine, 2005, 145: 125-33.
112. Nakamura T, Sugaya T, Kawagoe Y et al. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy. Diabetes care, 2005, 28: 2728-32.
113. Nakamura T, Sugaya T, Kawagoe Y et al. Candesartan reduces urinary fatty acid-binding protein excretion in patients with autosomal dominant polycystic kidney disease. The American journal of the medical sciences, 2005, 330: 161-5.
114. Abrahamson M, Olafsson I, Palsdottir A et al. Structure and expression of the human cystatin c gene. The Biochemical journal, 1990, 268: 287-94.
115. Grubb A. Diagnostic value of analysis of cystatin c and protein hc in biological fluids. Clinical nephrology, 1992, 38 Suppl 1: S20-7.
116. Tenstad O, Roald AB, Grubb A et al. Renal handling of radiolabelled human cystatin c in the rat. Scandinavian journal of clinical and laboratory investigation, 1996, 56: 409-14.
117. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin c is superior to serum creatinine as a marker of kidney function: A meta-analysis. American journal of kidney diseases: the official journal of the National Kidney Foundation, 2002, 40: 221-6.
118. Li Y, Fu C, Zhou X et al. Urine interleukin-18 and cystatin-c as biomarkers of acute kidney injury in critically ill neonates. Pediatr Nephrol, 2012
119. Herget-Rosenthal S, Marggraf G, Husing J et al. Early detection of acute renal failure by serum cystatin c. Kidney Int, 2004, 66: 1115-22.
120. Herget-Rosenthal S, Poppen D, Husing J et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem, 2004, 50: 552-8.
121. Knight EL, Verhave JC, Spiegelman D et al. Factors influencing serum cystatin c levels other than renal function and the impact on renal function measurement. Kidney Int, 2004, 65: 1416-21.
122. Ahlstrom A, Tallgren M, Peltonen S et al. Evolution and predictive power of serum cystatin c in acute renal failure. Clinical nephrology, 2004, 62: 344-50.
123. Grenier FC, Ali S, Syed H et al. Evaluation of the architect urine ngal assay: Assay performance, specimen handling requirements and biological variability. Clinical biochemistry, 2010, 43: 615-20.
124. Hu MC, Shi M, Zhang J et al. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol, 2011, 22: 124-36.
125. Kuro-o M. Klotho. Pflugers Archiv: European journal of physiology, 2010, 459: 333-43.
126. Hu MC, Shi M, Zhang J et al. Klotho deficiency is an early biomarker of renal ischemia-reperfusion injury and its replacement is protective. Kidney Int, 2010, 78: 1240-51.
127. Kuro-o M. Klotho and aging. Biochimica et biophysica acta, 2009, 1790: 1049-58.
128. Sugiura H, Yoshida T, Tsuchiya K et al. Klotho reduces apoptosis in experimental ischaemic acute renal failure. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, 2005, 20: 2636-45.
129. Yoon HE, Ghee JY, Piao S et al. Angiotensin ii blockade upregulates the expression of klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, 2011, 26: 800-13.
130. Cheng MF, Chen LJ, Cheng JT. Decrease of klotho in the kidney of streptozotocin-induced diabetic rats. Journal of biomedicine & biotechnology, 2010, 2010: 513853.
131. Sugiura H, Yoshida T, Mitobe M et al. Recombinant human erythropoietin mitigates reductions in renal klotho expression. American journal of nephrology, 2010, 32: 137-44.
132. Adijiang A, Niwa T. An oral sorbent, ast-120, increases klotho expression and inhibits cell senescence in the kidney of uremic rats. American journal of nephrology, 2010, 31: 160-4.
133. Yamazaki Y, Imura A, Urakawa I et al. Establishment of sandwich elisa for soluble alpha-klotho measurement: Age-dependent change of soluble alpha-klotho levels in healthy subjects. Biochemical and biophysical research communications, 2010, 398: 513-8.
134. Kelly KJ. Stress response proteins and renal ischemia. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2002, 54: 81-91.
135. Kelly KJ, Baird NR, Greene AL. Induction of stress response proteins and experimental renal ischemia/reperfusion. Kidney Int, 2001, 59: 1798-802.
136. Molinas SM, Rosso M, Wayllace NZ et al. Heat shock protein 70 induction and its urinary excretion in a model of acetaminophen nephrotoxicity. Pediatr Nephrol, 2010, 25: 1245-53.
137. Mueller T, Bidmon B, Pichler P et al. Urinary heat shock protein-72 excretion in clinical and experimental renal ischemia. Pediatr Nephrol, 2003, 18: 97-9.
138. Zhipeng W, Li L, Qibing M et al. Increased expression of heat shock protein (hsp)72 in a human proximal tubular cell line (hk-2) with gentamicin-induced injury. The Journal of toxicological sciences, 2006, 31: 61-70.
139. Fan CY, Lee S, Cyr DM. Mechanisms for regulation of hsp70 function by hsp40. Cell stress & chaperones, 2003, 8: 309-16.